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Leishmania major-infected TNF receptor 1 deﬁcient (TNFR1 KO) mice resolve parasitism but fail to resolve lesions, while wild-
type mice completely heal. We investigated the cell composition, cytokine production, and apoptosis in lesions from L. major-
infected TNFR1 KO and wild-type (WT) mice. Chronic lesions from L. major-infected TNFR1 KO mice presented larger number
of CD8+ T and Ly6G+ cells. In addition, higher concentrations of mRNA for IFN-γ CCL2 and CCL5, as well as protein, but lower
numbers of apoptotic cells, were found in lesions from TNFR1 KO mice than in WT, at late time points of infection. Our studies
showed that persistent lesions in L. major-infected TNFR1 KO mice may be mediated by continuous migration of cells to the site
of inﬂammation due to the presence of chemokines and also by lower levels of apoptosis. We suggest that this model has some
striking similarities to the mucocutaneous clinical form of leishmaniasis.
1.Introduction
Parasites of the genus Leishmania cause a spectrum of cuta-
neousmanifestationsrangingfromlimitedcutaneouslesions
that heal spontaneously to the more severe mucocutaneous
form. These diﬀerent clinical manifestations depend on the
species of Leishmania and the host immune response [1,
2]. In experimental models, it is established that BALB/c
mice are susceptible to infection by Leishmania major.
This mouse strain develops progressive lesions, uncontrolled
growth of parasites, visceralization, and death. The C57BL/6
strain is resistant to infection by L. major, controls parasite
replication, and heals lesions [3]. However, despite clinical
and pathological cure of the disease, the parasite remains
latent in the host. Resistance to infection by L. major is
mediated by IFN-γ,T N F - α, and activation of macrophages
to produce nitric oxide [4–6].
Mucocutanesous leishmaniasis is caused mainly by L.
braziliensis. It is characterized by control of parasite growth
in the tissue, but persistent chronic inﬂammation that com-
monly aﬀects mucosal tissue causing severe disﬁguration
and social stigma to the patient [7]. High concentrations
of inﬂammatory cytokines, namely, IFN-γ and TNF-α,a r e
found in these patients [8]. The study of mucocutaneous
leishmaniasis is hampered by lack of a good experimental
model. Experimental infection with L. braziliensis causes a
v e r ym i l da n ds e l f - l i m i t e dl e s i o ni nC 5 7 B L / 6a n dB A L B / c
strain mice [9, 10]. In addition, L. amazonensis causes a
persistentchroniclesioninC57BL/10andC57BL/6micethat
lasts over 20 weeks, but both animal models fail to control2 Clinical and Developmental Immunology
the parasite in the tissue, a hallmark of mucocutaneous
leishmaniasis. Moreover, IFN-γ and TNF production is
impaired in these infection models [11–13]. The closest
animal model for mucocutaneous disease would be the
infection of C57BL/6 TNFR1-deﬁcient (TNFR1 KO) mice
with L. major. TNFR1 KO mice control tissue parasitism
similarly to the wild-type resistant mouse, but develop
nonhealing lesions. However, these lesions do not increase in
size progressively. On the contrary, they remain chronic and
small, but last for at least 20 weeks afterinfection [14, 15].
In experimental infection by L. major, TNF-α is impor-
tant for activation of macrophages, in cooperation with IFN-
γ, and elimination of intracellular parasites [4, 5, 16–18].
Another important fact is the involvement of TNF in the
induction of apoptosis in lymphocytes from lesions from
wild-typeL.major-infectedmice[19].This information may
suggest that TNF-α may play a key role in the healing of
L. major lesions. However, this important phenomenon was
not described in the chronic stage of infection to explain the
persistent lesions in L. major-infected TNFR1 KO. Thus, the
aim of this study was to characterize events in the chronic
phase of L. major infection in TNFR1 KO mice.
2.MaterialsandMethods
2.1. Animals. C57BL/6 wild-type (WT) mice, 6 to 10 weeks
old, were obtained from CEBIO (Universidade Federal de
Minas Gerais, Belo Horizonte, MG, Brazil). TNFR1 KO mice
were originally obtained from the University of Pennsylvania
(Philadelphia, Pa, USA, a kind gift from Dr. Phillp Scott
and Dr. Klaus Pfeﬀer) and maintained in Laboratory of the
Gnotobiology and Immunology of the Instituto de Ciˆ encias
Biol´ ogicas (UFMG, Brazil). All the procedures involving
animals were in accordance with the ethical principles in
animal research adopted by the Brazilian College of Animal
Experimentation and were approved by the UFMG animal
experimentation ethical committee at UFMG (CETEA),
protocol number 55/2009.
2.2. Parasites and Infection. Ac l o n eo fLeishmania major
(WHO MHOM/IL/80/Friedlin) was used in this study. Pa-
rasites were maintained in Grace’s insect medium (GIBCO
BRL Life Technologies, Grand Island, NY, USA), pH 6.2,
supplemented with 20% fetal bovine serum (Nutricell,
Campinas, SP, Brazil), 2mM l-glutamine (SIGMA Chemical
Co.,St.Louis,Mo,USA),100U/mLpenicillinand100μg/mL
streptomycin (GIBCO BRL Life Technologies). Mice were
injectedinthehindfootpadswith1×106 L.major metacyclic
promastigotes. Footpads were measured weekly with a
caliper (Mitutoyou, Suzano, SP, Brazil). Lesion sizes are ex-
pressed as the diﬀerence between infected and uninfected
footpads.
2.3. Parasite Load. Parasite load in infected footpads was
determined by limiting dilution [14]. Results were expressed
as the negative log of the last positive dilution.
2.4. Histological Analyzes. Infected footpads from WT and
TNFR1 KO mice were removed at 6 and 15 weeks after
infection and ﬁxed in 10% of formalin. Tissues were pro-
cessed and embedded in paraﬃna n d5 μm thick sections
were stained with hematoxylin and eosin and analyzed by
light microscopy. At least 10 microscopic ﬁelds measuring
250,000 micrometers, representative of lesions, were auto-
maticallyanalysedbyKS300(CarlZeiss,Germany)fordeter-
mining the comparative cellularity of lesions at 15wks.
2.5. Apoptosis Analysis. Infected footpads from WT and
TNFR1 KO mice were removed at 6 and 11 weeks after
infection and ﬁxed in 4% formaldehyde. Apoptotic cells
were assessed in situ by the TUNEL reaction, an in situ
cell death detection kit (POD, Roche Applied Science,
Penzberg, Germany). The results were obtained by counting
the number of stained cells per 100 cells (600 cells counted
per animal) in 6–10 random areas per histological section.
2.6.FlowCytometry. InfectedfootpadsfromWTandTNFR1
KO mice were removed at 6 and 15 weeks after infec-
tion. Collected tissues were incubated for 90 minutes with
1.5mg/mL of collagenase (Sigma-Aldrich, Mo, USA) in
RPMI 1640 without supplements at 37◦C, homogenized
using a tissue grinder and centrifuged at 2000g. Single-
cell suspensions were stained with ﬂuorochrome-conjugated
antibodies (eBioscience, San Diego, Calif, USA) against CD4
(RM4-5), CD8 α (53-6.7), CD3 (17A2), F4/80 (BM8), and
Ly6G (RB6-8C5) in PBS containing 1% FBS for 20min
on ice and then washed and ﬁxed with 2% formaldehyde.
StainedcellswereanalyzedusinganFACScanﬂowcytometer
equipped with cellQuest software (Becton Dickinson, Hei-
delberg, Germany). Statistical analyses of mean ﬂuorescence
intensity (MFI) were performed using the FlowJo v7.6.5
software (Tree Star Inc., Ashland, Ore, USA).
2.7. Chemokines and Cytokines Analysis. Chemokines and
cytokineswereanalyzedbytwomethods:detectionofmRNA
by reverse transcription polymerase chain reaction (RT-
PCR) and ELISA, at diﬀerent times of infection (1 and 2
days, 2, 6, and 11 weeks). The footpad was excised and
total protein and RNA were extracted with Trizol (GIBCO
BRL Laboratories), as previously described. Cytokine and
chemokine detections by RT-PCR were performed as previ-
ously described [20]. Brieﬂy, L. major-infected and nonin-
fected footpads were harvested and placed in 0.5mL TRI-
ZOL (GIBCO BRL) solution and homogenized, and RNA
extraction was performed according to the manufacture’s
instruction. RNA was quantitated spectrophotometricaly
and 1μg of RNA was reverse transcribed using 25U of M-
MLV Reverse Transcriptase (Promega Corp., Madison, Wis,
USA) in 12.5μL reaction containing 2.5mM dNTPs, 50mM
TRIS/HCl (pH8.3), 75mM KCl, 2mM MgCl2,1 0 m M
D T T( G I B C OB R LL a b o r a t o r i e s ,G r a n dI s l a n d ,N Y ,U S A ) ,
250mM dNTP (Promega), 50mM Tris-HCl, pH 8.3, 75mM
KCl,3mMMgCl2,10mMDTT ,10URN Asin(GIBCOBRL),
and 7.5pM of oligo dT15 (GIBCO BRL). The mixtures were
incubated for 5min at 95◦C, 5min at 4◦C, and 5min at
25◦C; at this step 25U of reverse transcriptase was added
to each sample and the reaction mixture was incubatedClinical and Developmental Immunology 3
Table 1: Primers, temperature, and number of cycles used for RT-PCR.
Primer Sequence Length (bp)
HPRT
58◦C3 2c y c l e s 217
FW GTT GGA TAC AGG CCA GAC TTT GTT 546–569
RV GAT TCA ACT TGC GCT CAT CTT AGG C 763–739
IL-4
60◦C3 3c y c l e s 292
FW TTT GAA CGA GGT CAC AGG AG 195–214
RV TGC TCT TTA GGC TTT CCA GG 487–468
IFN-γ
60◦C3 2c y c l e s 202
FW GGT GAC ATG AAA ATC CTG CAG 290–310
RV GCG CTG GAC CTG TGG GTT GTT GAC C 493–469
TNF-α
62◦C3 0c y c l e s 300
FW CGC TCT TCT GTC TAC TGA AC 293–312
RV TGT CCC TTG AAG AGA ACC TG 593–574
CCL2
62◦C3 0c y c l e s 488
FW CCG GAA TTC CAC TCA CCT GCT GCT ACT CAT TCA 179–205
RV CCG GAA TTC GGA TTC ACA GAG AGG GAA AAA TGG 667–644
CCL5
54◦C2 6c y c l e s 309
FW CGC GGA TCC CCA CGT CAA GG A GTA TTT CTA CAC C 184–209
RV CGC GAA TCC CTG GTT TCT TGG GTT TGC TGT TG 493–473
CCL12
54◦C2 9c y c l e s 380
FW GTT CCT GAC TCC TCT AGC TTT C 11–32
RV ACG TAA GAG TTT TTG GAA CTC 391–371
CXCL9
54◦C3 0c y c l e s 398
FW GAT CAA ACC TGC CTA GAT CC 302–321
RV GGC TGT GTA GAA CAC AGA GT 700–681
CXCL10
62◦C2 7c y c l e s 383
FW CGC GGA TCC TGA GCA GAG ATG TCT GAA TC 250–271
RV CGC GGA TCC TCG CAC CTC CAC ATA GCT TAC AG 633–611
CXCL1
62◦C3 4c y c l e s 521
FW CGC GGA T:CC TGG ACC CTG AAG CTC CCT TGG TTC 226–251
RV CGC GGA TCC: CGT GCG TGT TGA CCA TAC ATT ATG 731–708
for 60min at 37◦C. The temperature was then elevated to
95◦Cf o r5 m i na n dc o o l e da g a i na t4 ◦C for 5min. The
PCR was performed in 10μL reaction of samples diluted in
the following buﬀer: 250mM dNTP, 10mM Tris-HCl pH
8.3, 50mM KCL, 1.5mM MgCl2,5m Mo fe a c hp r i m e ra n d
0.05U of TaqPolimerase (Phoneutria, Belo Horizonte, MG,
Brazil). For each pair of primers, at least three diﬀerent
numbers of cycles were tested and the best nonsaturating
condition was chosen. The PCR was standardized using the
house-keeping gene HPRT. The primer sequences (sense
and antisense sequence), PCR product size, number of
cycles, and temperature of annealing used for each primer
are listed in Table 1. The products were electrophoresed in
6% polyacrilamide gels and developed by silver staining.
Primers and PCR conditions are listed in Table 1. For ELISA,
footpads were homogenized in PBS (0.4M NaCl and 10mM
de Na2HPO4, pH 7.2) containing antiproteases (0.1mM
phenylmehtylsulfonylﬂuoride,0.1mMbenzethoiniumchlo-
r i d e ,1 0m ME D T A ,a n d2 0m MK Ia p r o t i nA / 1 0 0m L )a n d
0.05% tween-20. Homogenized tissues were kept on ice for
30min and subsequently centrifuged (3000×g for 10min).
The preparations were assayed using RD Systems kits
(Duoset-RD Systems, Minneapolis, Minn, USA) according
to instructions. The sensitivity for CCL-2 and CCL-5 was 16
and 32pg/mL, respectively.
3. Results
Inthiswork,wecharacterizedthelesionsinL.major-infected
TNFR1 KO mice and attempted to explain the reason why
these lesions fail to heal. As shown previously [14] L.
major-infected TNFR1 KO mice develop chronic nonhealing
lesions, while WT mice heal lesions over time (Figure 1(a)).
In addition, as previously described [14], parasite growth is
controlled at the site of infection (Figure 1(b)). WT mice
had completely healed lesions at 15 weeks of infection;
however, TNFR1 KO mice had conspicuous lesions that led
to some loss of function (Figure 1(c)). When histological
examination of lesions was performed, we found that, albeit
at6weeksofinfectiontheinﬂammatoryinﬁltratewassimilar
in both groups, at 15 weeks very few inﬂammatory cells
were observed in WT mice, while lesions from TNFR1 KO4 Clinical and Developmental Immunology
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Figure 1: Lesions and parasite burdens in TNFR1 KO mice with L. major. Mice were infected with 1 × 106 metacyclic stationary forms of
L. major in footpads. (a) The footpads were measured weekly and the value for uninfected mice was subtracted from each infected footpad
to estimate lesion size. (b) Parasite burden in WT and TNFR1 KO mice. Mice were sacriﬁced at 6 and 15 weeks afterinfection and parasite
burden was determined by limiting dilution analysis (n = 5 mice per time point). (c) Lesions from WT and TNFR1 KO mice infected with L.
major 15 weeks afterinfection. (d–g) Histological aspect of tissues from lesions from WT and TNFR1 KO infected for 6 weeks (d and e) or 15
weeks (f and g), stained with hematoxylin and eosin. (h) Morfometric quantiﬁcation of inﬂammatory cells from WT and TNFR1 KO lesions
15 weeks afterinfection (n = 4 mice per group). ∗indicates P<0.05. Data are from one experiment of three performed independently.Clinical and Developmental Immunology 5
displayed a high number of inﬂammatory cells (Figures
1(d)–1(h)).
We further characterized the inﬂammatory inﬁltrate by
ﬂow cytometry. As seen in Figure 2(a), a higher percentages
of CD4+ T lymphocytes was found in lesions from WT
mice at 15 weeks of infection. However, since there were
more cells in the inﬂammatory inﬁltrate in TNFR1 mice,
when we calculated the absolute numbers of cells, similar
numbers of CD4+ cells were observed in lesions from
both groups of mice (Figure 2(b)). Higher percentages and
absolutenumbersofCD8+Tcellswerefoundinlesionsfrom
TNFR1 KO mice (Figures 2(a) and 2(b)). Also, at 15 weeks of
infectionahigherpercentageofmacrophages(F4/80positive
cells) was found in WT mice (Figure 2(c)), while a higher
percentage of Ly6G positive cells was found in TNFR1 KO
mice (Figure 2(c)). In absolute numbers, we found similar
numbers of CD4+ T cells and F4/80 cells in both groups
of mice (Figure 2(d)) while a higher absolute number of
Ly6G+ cells were found in lesions from TNFR1 KO mice
(Figure 2(d)). In addition, expression of Ly6G on a per cell
basis, indicated by the mean ﬂuorescence intensity (MFI),
was increased in these mice (Figure 2(e)).
We proceeded to investigate the expression of cytokines
at the site of infection. As seen in Figure 3(a), similar
concentrations of mRNA for TNF-α were found in both
groups of mice. Similar concentrations of IFN-γ mRNA were
found in lesions from both groups at 24 and 48 hours of
infection, but higher concentrations were found in lesions
from TNFR1 KO mice at 11 weeks of infection (Figure 3(b)).
In addition, similar concentrations of IL-4 message were
found in both groups at all time points tested. These data
were conﬁrmed by ELISA at 15 weeks of infection. We found
higher TNF-α and IFN-γ protein concentrations in L. major-
infected TNFR1KO mice (Figures 3(d) and 3(e)) than in WT
mice. No diﬀerences were found for IL-4 protein expression
between groups of mice (Figures 3(c) and 3(f)).
Since there were more cells at the site of infection in
TNFR1 KO mice, we investigated the expression of chemok-
ines by RT-PCR and ELISA. When we assayed CC cytokines,
as seen in Figure 4, we found that at 11 weeks of infection
there was higher expression of CCL2 and CCL5 mRNA
in L. major-infected TNFR1 KO mice than in WT mice
(Figures 4(a) and 4(b)). No diﬀerences were found in
expression of CCL12 mRNA between the groups of mice
(Figure 4(c)). We conﬁrmed the results found for CCL2 and
CCL5 by ELISA and found higher concentrations of protein
(Figures 4(d) and 4(e)) at 20 weeks of infection in lesions
from TNFR1 KO mice. In addition, no diﬀerences at later
time points were found for CXCL1, CXCL9, and CXCL10
mRNA (data not shown).
In addition to more recruitment, a larger cellular
population at the site of infection may be explained by
a defective removal of inﬂammatory cells. Since TNFR1
mediates apoptosis [19, 21], we investigated apoptosis at the
site of infection at 6 and 11 weeks by the TUNEL reaction.
As seen in Figure 5 and quantiﬁed in Table 2,a ts i xw e e k so f
infection we saw TUNEL-positive cells in both TNFR1 KO
and WT mice. However, at 11 weeks of infection we found
higher numbers of TUNEL positive cells in WT mice.
4. Discussion
Cutaneous leishmaniasis is characterized by lesions that
are self-limited and may heal spontaneously over time.
However, approximately 3% of infected individuals develop
the mucocutaneous form of the disease, with chronic
ulcerativelesionsaﬀectingmucosaltissuesandcartilage.One
of the features in mucocutaneous leishmaniasis in humans
is the prolonged maintenace of lesions [7, 22]. These tissues
present an inﬂammatory inﬁltrate rich in mononuclear and
polymorphonucelar cells [23–26]. High concentrations of
IFN-γ,TNF -α,andIL-17arefoundinaﬀectedtissuesandare
produced by peripheral blood monocuclear cells from these
patients [8, 26, 27]. Another feature is a deﬁciency in the
regulation of the inﬂammatory processes in mucocutaneous
patients, when compared to patients who developed the
cutaneous form of the disease [27]. Tissue damage is caused
apparently by the inﬂammatory response, since parasites are
detected in low concentrations or not at all in lesions [23–
25,28].Inthiswork,westudiedthechroniccutaneouslesion
developed by L. major-infected TNFR1 KO mice. This model
presents some of the features found in mucocutaneous
patients: control of parasite replication, high concentrations
of IFN-γ and TNF-α, and a large uncontrolled inﬂammatory
inﬁltrate. Hence, L. major-infected TNFR1 KO mice can
control parasite replication, but do not overcome the intense
inﬂammatory process that is observed even after 20 weeks
of infection. Thus, lesions in L. major-infected TNFR1 KO
mice present some similarities to mucocutaneos lesions in
patients infected (Table 2). This model may be useful for
studies aimed at interfering with the development of chronic
nonhealing lesions caused by Leishmania.
Resolution of L. major growth in mice is mediated by
nitric oxide produced by nitric oxide synthase 2 (NOS2),
which is induced by IFN-γ and TNF-α [4–6]. Given the high
concentrations of IFN-γ and TNF-α present in lesions from
TNFR1 KO mice infected with L. major, it is not surprising
that these mice control parasite growth. The reason for
discrepancy between mRNA and protein expression of TNF-
α is not known, but we could speculate that there is
posttrancriptional regulation or that protein is accumulated
at the site of infection, since there is no signaling through
TNFR1. Albeit TNF-α was shown to signal through TNFR1
to induce NOS2, alternative pathways in TNFR1 KO mice
have been proposed [15, 29, 30]. In fact, mice deﬁcient in
both receptors for TNF are capable of controlling parasite
burdens [15], and it has been proposed that direct contact
withTcells(viaCD40LandLFA1)wouldsubstituteforTNF-
α [29]. Thus, as previously described [14, 15], we show here
that persistence of lesions in TNFR1 KO is not mediated by
the persistence of parasites at the site of infection.
TNF-α is the starting factor that mediates cell inﬁltration
to a site of infection or tissue damage [21]. Accordingly, it
has been shown that in an HSV-1 encephalites mouse model,
TNFR1 mice present a smaller cellular inﬁltrate in response
to tissue damage [31]. In other models, it has been shown
that TNFR1 KO mice do not control the inﬂammatory
inﬁltrate and damage tissue [19, 30, 32–35]. In this work,
wecharacterizedthecellularinﬁltrateinlesionsfromTNFR16 Clinical and Developmental Immunology
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na¨ ıve mice (NI), and mice infected for 11 and 20 weeks. Data shown are from a single experiment representative of two separate experiments
p e r f o r m e dw i t hf o u rm i c ep e rg r o u p .∗P<0.05.Clinical and Developmental Immunology 9
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Figure 5: Apoptosis in lesions from WT and TNFR1 KO mice infected by L. major. Mice were infected with L. major in the footpad (1×106)
and after 6 weeks (a and b) and 11 weeks (c and d) of infection. Tissues were stained by TUNEL, as described in Section 2. Arrows indicate
TUNEL positive cells.
KO mice. We found that, at later times of infection, there
were more neutrophils and CD8+ T cells in lesions from
TNFR1 KO than in WT mice. CD8+ T cells have been
implicated in the exacerbation of tissue injury in patients
suﬀering from mucocutaneous form of leishmaniasis [36–
38].Likewise,thepresenceofneutrophilshasbeenassociated
with a high concentration of IL-17 in areas of tissue damage
in patients infected with L. braziliensis who developed
mucocutaneous leishmaniasis [25, 26]. We also found lower
percentagesofF4/80-expressingmacrophagesinlesionsfrom
TNFR1 KO mice at 15 weeks afterinfection. This seems
to be due to the presence of other cells in the same gate
(e.g., neutrophils), since absolute numbers of macrophages
were similar in both groups of mice. However, the smaller
percentage of macrophages (which is not a smaller absolute
number) did not compromise the control of parasites by
TNFR1 KO mice.
Cell recruitment to sites of infection or tissue damage is
mediated by chemokines [39]. In an attempt to explain the
larger cellular inﬁltrate in TNFR1 KO mice, we determined
the concentrations of mRNA for chemokines at several
times of infection. At the earlier times of infection the
concentrations of the chemokines assessed were similar in
both groups. This observation is in accordance with our
previous observations that initial cellular recruitment is
not aﬀected by the TNFR1, in a model of angiogenesis
[40]. However, at 11 weeks of infection, when lesions were
signiﬁcantly diﬀerent, we found higher expression of CCL5
and CCL2 mRNA and, at 20 weeks afterinfection, we found
higher concentrations of CCL5 and CCL2 protein in lesions.
This could be simply due to a larger number of cells at the
site of infection; however, this is unlikely, since for CCL12
and other chemokines (not shown) we failed to observe the
sameeﬀect.CCL5andCCL2areimplicatedonthemigration
ofmacrophages,monocytes,NK,andTcellstositesofinjury
[41–43]. Thus, it may be that the persistence of exacerbated
inﬂammatory cells at the site of infection with L. major in
TNFR1 KO is related with high concentrations of these two
chemokines that are promoting the recruitment of more
cells.
Apoptosis is required for the clearance of inﬂammatory
cells from tissues, once the stimulus for recruitment of
pathogens or damage is gone [44, 45]. TNFR1 mediates
apoptosis, since it contains a cell death domain [46, 47]. In
fact, it had previously been shown that there was defective
apoptosis at the site of infection of Rhodococcus equis.M o r e -
over, cells from R. equis- i n f e c t e dl u n g so fW Tm i c ea n df r o m
footpadsofL.major-infectedWTweresensitiveonlytoTNF-
mediated apoptosis. However, cells from TNFR1 KO mice
infected with either R. equis or L. major were not sensitive10 Clinical and Developmental Immunology
Table 2: Quantiﬁcation of apoptosis at the site of infection by L. major in WT and TNFR1 KO mice.
C57BL/6a TNFR1 KO
Mean Standard error Mean Standard error
6w e e k s 7.04b 0.72 6.75 1.00
11 weeks 8.15c 1.01 2.91 0.52
aMice were infected with L. major in the footpad (1×106) and after 6 and 11 weeks of infection animals were sacriﬁced and the lesions collected. Tissues were
stained by TUNNEL, as described in Section 2. Apoptotic nuclei were counted and results expressed as apoptotic nuclei per 100 nuclei. Results represent the
mean of 3–6 animals; six sections were counted per mouse.
bP = 0.37 Student’s t-test.
cP = 0.0005 Student’s t-test.
Table 3: Comparison between human mucocutaneous and TNFR1 KO lesions.
Characteristic Mucocutaneous
leishmaniasis
L. major-infected
TNFR1 KO
Chronic cutaneous lesions Yes Yes
Intense inﬂammatory cells inﬁltrate in chronic phase Yes Yes
Low parasite load in lesions Yes Yes
High production of proinﬂammatory cytokines (IFN-γ and TNF-α) in the lesions Yes Yes
Defect in the regulation of inﬂammatory response Yes Yes
Presence of high numbers of CD8+ T cells and neutrophils in lesions Yes Yes
High levels of IL-17 Yes Not determined
Invasion of mucosal tissues Yes No
to TNF-α-mediated apoptosis [19]. Thus, we investigated
apoptosis, in situ, in lesions from WT and TNFR1 KO mice.
At 6 weeks of infection, both mouse strains showed similar
concentrations of TUNEL positive cells, thus suggesting that
at this time point apoptosis occurred independently of the
TNFR1. However, at 11 weeks of infection, when WT mice
were healing and TNFR1 KO mice had a large inﬂammatory
inﬁltrate at the site of infection, lesions from WT mice had
signiﬁcantly more TUNEL positive cells than lesions from
TNFR1 KO mice. This indicated to us that TNFR1 plays a
crucial role in the clearance of the inﬂammatory inﬁltrate
and in the healing of lesions.
5. Conclusion
In this paper, we implicated persistent chemokine produc-
tion and defective apoptosis as the factors that prevent
healing of lesions in TNFR1 KO mice. In addition, charac-
terization of parasite burden, cellular inﬁltrate, and cytokine
production allowed us to propose the TNFR1 KO infected
with L. major as a model to study chronic nonhealing lesions
found in patients that present the mucocutaneous clinical
form of leishmaniasis (Table 3).
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